New York: Cranberries can help curb recurrent urinary tract infections (UTIs), the second most common type of infection in the body, says a study by an Indian-origin researcher.
A lower number of infections would mean less use of antibiotics and less risk of developing antibiotic resistance.
In addition, the unique blend of polyphenol antioxidants — provided by cranberries — may assist in preserving the heart and cognitive health, and protect against oxidative stress to help promote overall well-being, the findings showed.
“We have long believed in the urinary tract health benefits that cranberries provide, but this new research reveals just how wide-ranging those benefits can be,” said Kalpana Gupta, professor of medicine at Boston University School of Medicine in the US.
Gupta highlighted that rising resistance across multiple classes of drugs has made oral options for UTIs often limited and sometimes non-existent.
The findings suggest that cranberries are powerful and may provide whole-body health benefits.
The findings were presented recently at the seventh International Conference on Polyphenols and Health (ICPH 2015) in France.
Higher sodium intake should not be used as a treatment for lightheadedness, say researchers challenging current guidelines for sodium consumption.
Lightheadedness while standing, known as postural lightheadedness, results from gravitational drop in blood pressure and is common among adults.
Greater sodium intake is widely viewed as an intervention for preventing lightheadedness when moving from seated to standing positions.
However, contrary to this recommendation, researchers at Beth Israel Deaconess Medical Centre (BIDMC) found that higher sodium intake, actually increases dizziness.
“Our study has clinical and research implications,” said Stephen Juraschek, researcher from BIDMC in Boston.
“Our results serve to caution health practitioners against recommending increased sodium intake as a universal treatment for lightheadedness. Additionally, our results demonstrate the need for additional research to understand the role of sodium, and more broadly of diet, on lightheadedness,” Juraschek said.
For the study, reported in The Journal of Clinical Hypertension, the team used data from the completed DASH-Sodium trial, a randomised crossover study that looked at the effects of three different sodium levels (1500, 2300, and 3300 mg/d) on participants’ blood pressure for four weeks.
While the trial showed that lower sodium led to decrease in blood pressure, it also suggested that concerns about lower level of sodium causing dizziness may not be scientifically correct.
The study also questioned recommendations to use sodium to treat lightheadedness, an intervention that could have negative effects on cardiovascular health.
“Health practitioners initiating sodium interventions for orthostatic symptoms now have some evidence that sodium might actually worsen symptoms,” Juraschek said.
“Clinicians should check on symptoms after initiation and even question the utility of this approach. More importantly, research is needed to understand the effects of sodium on physical function, particularly in older adults.” (IANS)